Explore more publications!

Press Releases

Oculis to Participate in Upcoming Investor Conferences
Alvotech Files Annual Report with the SEC
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis
From design to daily operations: Flashnet's customer-centric support services for more reliable smart street lighting
2025 full year financial results

2025 full year financial results

Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older
Alvotech Q4 2025 and Full Year 2025 Financial Results
VIVUS Reinforces QSIVA®’s Clinical Efficacy and Safety in Obesity Management
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
The Arctic This Week Take Five: Week of 23 March, 2026

The Arctic This Week Take Five: Week of 23 March, 2026

VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
Tests of fridges show positive results
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
Critical Resource Race: The Multi-Billion Dollar Move Toward Secure Supply Chains

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions